Get the Stockscreener App
0.5181
8.70%
-0.0494
Alx Oncology Holdings Inc stock is traded at $0.5181, with a volume of 415.90K.
It is down -8.70% in the last 24 hours and up +19.57% over the past month.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
See More
Previous Close:
$0.5675
Open:
$0.55
24h Volume:
415.90K
Relative Volume:
0.80
Market Cap:
$27.66M
Revenue:
-
Net Income/Loss:
$-151.16M
P/E Ratio:
-0.1744
EPS:
-2.97
Net Cash Flow:
$-130.08M
1W Performance:
-1.54%
1M Performance:
+19.57%
6M Performance:
-64.51%
1Y Performance:
-81.50%
1-Day Range:
$0.51
$0.55
1-Week Range:
$0.51
$0.636
52-Week Range:
$0.404
$3.02
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
Name
Alx Oncology Holdings Inc
Sector
Industry
Phone
650-466-7125
Address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Compare ALXO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
0.5181 | 30.33M | 0 | -151.16M | -130.08M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-19-24 | Downgrade | Jefferies | Buy → Hold |
| Mar-08-24 | Downgrade | Stifel | Buy → Hold |
| Dec-08-23 | Upgrade | Jefferies | Hold → Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-30-21 | Initiated | Stifel | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Apr-06-21 | Initiated | UBS | Buy |
| Feb-10-21 | Initiated | H.C. Wainwright | Buy |
| Aug-11-20 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-11-20 | Initiated | Credit Suisse | Outperform |
| Aug-11-20 | Initiated | Jefferies | Buy |
| Aug-11-20 | Initiated | Piper Sandler | Overweight |
View All
Alx Oncology Holdings Inc Stock (ALXO) Latest News
Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionQuick Profit Setup with Signal Forecast - Newser
What institutional flow reveals about ALX Oncology Holdings Inc.Profitable Trading Blueprint with Entry Zones - Newser
What indicators show strength in ALX Oncology Holdings Inc.Free Fundamental Growth Stock Analysis - Newser
Trapped Investors in ALX Oncology Holdings Inc. Await Breakout SignalCommunity Verified Stock Suggestions Drive Volume - metal.it
How volatile is ALX Oncology Holdings Inc. stock compared to the marketExpert Picks Watchlist For 2025 - jammulinksnews.com
Will ALX Oncology Holdings Inc. see short term momentumChart Pattern Recognition for Profit Timing - Newser
How to read the order book for ALX Oncology Holdings Inc.ROI Prediction from Long-Term Holding Plans - Newser
What are ALX Oncology Holdings Inc. company’s key revenue driversTop Growth Signals From AI Tools - jammulinksnews.com
Top chart patterns to watch in ALX Oncology Holdings Inc.Free Triple Digit Growth Focused Trade Plan - Newser
How does ALX Oncology Holdings Inc. generate profit in a changing economyTop Growth Review With High Returns - jammulinksnews.com
How to interpret RSI for ALX Oncology Holdings Inc. stockAI Volatility Forecast and Risk Monitor - Newser
Has ALX Oncology Holdings Inc. formed a bullish divergenceFree AI Trading Suggestions With Accuracy Focus - Newser
Published on: 2025-07-31 02:51:19 - metal.it
When is the best time to buy ALX Oncology Holdings Inc. stockFree Entry Alert Based on Volume Spikes - Newser
Chart overlay techniques for tracking ALX Oncology Holdings Inc.Machine Learning Intraday Signal Forecast - Newser
Tools to assess ALX Oncology Holdings Inc.’s risk profileWeekly Growth Portfolio Performance Summary - Newser
Competitive Positioning of ALX Oncology Holdings Inc.: Is It Leading or LaggingLong-Term Investment Strategy Summary Guide - Newser
ALXO’s Stock Dilemma: Alx Oncology Holdings Inc’s Market Performance and Outlook - investchronicle.com
Top Risks to Consider Before Buying ALX Oncology Holdings Inc. StockEntry Timing with Downside Risk Analysis - Newser
How Interest Rate Changes Impact ALX Oncology Holdings Inc. Stock Performance - Newser
Developing predictive dashboards with ALX Oncology Holdings Inc. dataFree Real Profit Trade Plan Suggestions - Newser
Published on: 2025-07-29 00:54:16 - metal.it
What institutional investors are buying ALX Oncology Holdings Inc. stockCapitalize on stocks with high profit margins - jammulinksnews.com
What are analysts’ price targets for ALX Oncology Holdings Inc. in the next 12 monthsUnmatched profit growth - jammulinksnews.com
Is ALX Oncology Holdings Inc. stock overvalued or undervaluedAchieve breakthrough gains with expert advice - jammulinksnews.com
What catalysts could drive ALX Oncology Holdings Inc. stock higher in 2025Breakthrough financial growth - jammulinksnews.com
What makes ALX Oncology Holdings Inc. stock price move sharplyMaximize returns with effective portfolio management - jammulinksnews.com
What is ALX Oncology Holdings Inc. company’s growth strategyAchieve rapid portfolio appreciation - jammulinksnews.com
When is ALX Oncology Holdings Inc. stock expected to show significant growthTremendous portfolio expansion - jammulinksnews.com
Is it the right time to buy ALX Oncology Holdings Inc. stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What makes BYON stock price move sharplyFree Access to Community - Newser
Alx Oncology Holdings Inc Stock (ALXO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alx Oncology Holdings Inc Stock (ALXO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pinto Shelly | SVP, FINANCE AND CAO |
Jun 30 '25 |
Sale |
0.43 |
1,532 |
659 |
88,820 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Feb 19 '25 |
Sale |
1.15 |
550 |
633 |
87,352 |
| Pons Jaume | PRESIDENT & CSO |
Feb 19 '25 |
Sale |
1.15 |
1,326 |
1,525 |
579,388 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Feb 19 '25 |
Sale |
1.15 |
2,159 |
2,483 |
170,270 |
| Pinto Shelly | Interim CFO |
Jan 06 '25 |
Sale |
1.80 |
2,221 |
3,998 |
87,902 |
| Pinto Shelly | Interim CFO |
Dec 30 '24 |
Sale |
1.58 |
1,426 |
2,253 |
90,123 |
| Pons Jaume | PRESIDENT & CSO |
Dec 30 '24 |
Sale |
1.58 |
10,796 |
17,060 |
580,714 |
| Hemrajani Rekha | Director |
Dec 02 '24 |
Buy |
1.55 |
30,000 |
46,404 |
33,000 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Aug 14 '24 |
Sale |
2.58 |
564 |
1,455 |
91,549 |
| Randolph Sophia | CHIEF MEDICAL OFFICER |
Aug 14 '24 |
Sale |
2.58 |
1,365 |
3,522 |
325,711 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):